| Financial Year |
March 31 2023 |
| Monetary Funds |
202,391,124.79 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,500,000.00 |
| Accounts Receivable |
850,124,374.00 |
| Advances to Suppliers |
66,382,220.10 |
| Other Receivables |
50,912,290.40 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
668,356,613.39 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
95,911,925.39 |
| Total Current Assets |
2,005,573,086.17 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
168,450,000.00 |
| Long-term Equity Investment |
1,999,191.12 |
| Investment Properties |
26,481,509.21 |
| Fixed Assetes |
961,294,816.06 |
| Under-construction Projects |
458,413,427.45 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
168,416,148.92 |
| R&D expenses |
81,791,177.79 |
| Goodwill |
7,919,738.93 |
| Long-Term Deferred and Prepaid Expenses |
36,518,957.72 |
| Deferred Income Tax Assets |
41,350,282.16 |
| Other Non-Current Assets |
39,607,085.31 |
| Sub-Total of Non-Current Assets |
2,402,309,130.13 |
| Total Assets |
4,407,882,216.30 |
| Short-Term Loans |
405,740,986.12 |
| Trading Financial liabilities |
-- |
| Notes Payable |
169,900,000.00 |
| Accounts Payable |
564,288,910.83 |
| Accounts Received In Advance |
106,584.01 |
| Employee Compensation Payable |
46,370,775.59 |
| Taxes Payable |
48,325,972.54 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
630,626,480.22 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
117,477,885.25 |
| Other Current Liabilities |
15,002,150.66 |
| Sub-Total of Current Liabilities |
2,129,845,173.85 |
| Long-term Loans |
274,179,604.88 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
28,300,596.28 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
469,245,140.48 |
| Total Liabilities |
2,599,090,314.33 |
| Paid-In Capital(Or Share Stock) |
332,111,230.00 |
| Capital Surplus |
545,495,911.90 |
| Surplus Reserve |
40,778,153.80 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
810,384,425.25 |
| Minority Stockholder's Interest |
25,973,448.15 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,782,818,453.82 |
| Owner's Equity（Stockholder's Equity） |
1,808,791,901.97 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,407,882,216.30 |
